Magazine Article | June 1, 2021

The Lasting Impact Of COVID-19 On Emerging Life Sciences Supply Chain

Source: Life Science Leader

By Bill Connell & Dave Stowe

The COVID pandemic brought disruption to pharmaceutical and life sciences supply chains, and despite the best efforts and preparation the industry is known for, the fallout continues to reverberate.

Although the COVID pandemic was unprecedented, the disruptions it caused are not, as this pandemic merely exposed supply chain weaknesses already there. For example, something as simple as glass vials and packaging materials saw a big spike in global demand as the COVID-19 vaccine impacted downstream supply markets. In the wake of the pandemic, life sciences companies are just now beginning to understand that they were not as prepared for major disruptions as they thought, and that this lack of preparation can adversely impact business performance.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: